These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 39075633)

  • 81. The combined effect of transferrin saturation and low density lipoprotein on mortality.
    Wells BJ; Mainous AG; King DE; Gill JM; Carek PJ; Geesey ME
    Fam Med; 2004 May; 36(5):324-9. PubMed ID: 15129378
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan.
    Hirata T; Sugiyama D; Nagasawa SY; Murakami Y; Saitoh S; Okayama A; Iso H; Irie F; Sairenchi T; Miyamoto Y; Yamada M; Ishikawa S; Miura K; Ueshima H; Okamura T;
    Eur J Epidemiol; 2017 Jul; 32(7):547-557. PubMed ID: 27709448
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.
    Castañer O; Pintó X; Subirana I; Amor AJ; Ros E; Hernáez Á; Martínez-González MÁ; Corella D; Salas-Salvadó J; Estruch R; Lapetra J; Gómez-Gracia E; Alonso-Gomez AM; Fiol M; Serra-Majem L; Corbella E; Benaiges D; Sorli JV; Ruiz-Canela M; Babió N; Sierra LT; Ortega E; Fitó M
    J Am Coll Cardiol; 2020 Dec; 76(23):2712-2724. PubMed ID: 33272365
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Risk of cardiovascular mortality in relation to optimal low-density lipoprotein cholesterol combined with hypertriglyceridemia: is there a difference by gender?
    Kuklina EV; Keenan NL; Callaghan WM; Hong Y
    Ann Epidemiol; 2011 Nov; 21(11):807-14. PubMed ID: 21982483
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.
    Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cholesterol paradox in the community-living old adults: is higher better?
    Wang SS; Yang SS; Pan CJ; Wang JH; Li HW; Chen SM; Hao JK; Li XH; Li RR; Li BY; Yang JH; Shi YT; Li HH; Bao YH; Wang WC; DU SY; He Y; Li CL; Liu M
    J Geriatr Cardiol; 2023 Dec; 20(12):837-844. PubMed ID: 38161338
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial.
    Giugliano RP; Wiviott SD; Blazing MA; De Ferrari GM; Park JG; Murphy SA; White JA; Tershakovec AM; Cannon CP; Braunwald E
    JAMA Cardiol; 2017 May; 2(5):547-555. PubMed ID: 28291866
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.
    Lee Y; Park S; Lee S; Kim Y; Kang MW; Cho S; Park S; Han K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    PLoS One; 2020; 15(4):e0231328. PubMed ID: 32271842
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality.
    Cui Y; Blumenthal RS; Flaws JA; Whiteman MK; Langenberg P; Bachorik PS; Bush TL
    Arch Intern Med; 2001 Jun; 161(11):1413-9. PubMed ID: 11386890
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
    Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
    Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Serum Low-Density Lipoprotein Cholesterol Level After Endovascular Therapy in Patients With Claudication.
    Tomoi Y; Yamaji K; Soga Y; Hiramori S; Ando K
    J Endovasc Ther; 2019 Jun; 26(3):402-410. PubMed ID: 30873910
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Association of high-density lipoprotein cholesterol with all-cause and cause-specific mortality in a Chinese population of 3.3 million adults: a prospective cohort study.
    Lu J; Han G; Liu X; Chen B; Peng K; Shi Y; Zhang M; Yang Y; Cui J; Song L; Xu W; Yang H; He W; Zhang Y; Tian Y; Li Y; Li X
    Lancet Reg Health West Pac; 2024 Jan; 42():100874. PubMed ID: 38357392
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The Association of Small Dense Low-Density Lipoprotein Cholesterol and Coronary Heart Disease in Subjects at High Cardiovascular Risk.
    Higashioka M; Sakata S; Honda T; Hata J; Shibata M; Yoshida D; Goto K; Kitazono T; Osawa H; Ninomiya T
    J Atheroscler Thromb; 2021 Jan; 28(1):79-89. PubMed ID: 32307338
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The Mutual Impact of Smoking and Low Cholesterol on All-Cause, Non-Cardiovascular, and Cardiovascular Mortalities in Males.
    Parsa N; Taravatmanesh S; Trevisan M; Zaheri PM
    Am J Mens Health; 2018 Nov; 12(6):2128-2135. PubMed ID: 30136632
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Association between remnant cholesterol and the risk of cardiovascular disease in Chinese population.
    Jiang X; Zhuang J; Juan Y; Zheng X; Zhang H
    J Stroke Cerebrovasc Dis; 2024 Aug; 33(8):107825. PubMed ID: 38914356
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Association of weight change with all-cause and cause-specific mortality: an age-stratified analysis.
    Huang QM; Shen D; Gao J; Chen H; Xie JH; Yan HY; Wu B; Li ZH; Liu G; Mao C
    BMC Med; 2024 Oct; 22(1):438. PubMed ID: 39379988
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.